abstract |
The present invention relates to an isolated, non-naturally occurring delivery construct comprising a bacterial toxin-derived delivery construct bound to a biologically active therapeutic cargo; The delivery construct is capable of delivering a biologically active cargo via transit exocytosis across epithelial cells; The delivery construct does not include a bacterial-toxin derived translocation domain or a bacterial-toxin derived catalytic (cytotoxic) domain. |